Schedule 13G ownership disclosure
AKERO THERAPEUTICS INC
Security class unavailable · CUSIP: 00973Y108
Event date: 2020-08-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,507,228
- Percent of class
- 10.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-20-002410
- Form type
- SC 13G
- Filer
- Akero Therapeutics, Inc.
- CIK
- CIK 1744659
- Filed
- Sep 10, 2020
- Reporting period
- Aug 31, 2020
- Description
- Schedule 13G beneficial ownership